Protalix Biotherapeutics, Inc. (PLX)
3.00
-0.14
(-4.46%)
USD |
NYAM |
Feb 24, 16:00
3.00
0.00 (0.00%)
After-Hours: 20:00
Protalix Biotherapeutics Market Cap : 241.26M for Feb. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Denali Therapeutics, Inc. | 3.346B |
| OraSure Technologies, Inc. | 202.29M |
| Nephros, Inc. | 41.23M |
| Agenus, Inc. | 116.38M |
| Curis, Inc. | 13.96M |
Market Cap Related Metrics
| PE Ratio | 43.17 |
| PS Ratio | 3.815 |
| Price to Book Value | 4.560 |
| Price | 3.00 |
| Earnings Yield | 2.32% |
| Operating PE Ratio | 37.05 |
| Normalized PE Ratio | 43.17 |